Skip to content

Radiation Medicine Patient Registry, Loma Linda University Medical Center

Loma Linda University Medical Center Department of Radiation Medicine Patient Registry

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02436941
Enrollment
75000
Registered
2015-05-07
Start date
2003-10-20
Completion date
2050-10-01
Last updated
2026-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Brief summary

For most cancers, long-term follow-up is the best measure of treatment effectiveness. The Department of Radiation Medicine at Loma Linda University Medical Center operates the James M. Slater, M.D., Proton Treatment and Research Center, the world's first hospital-based proton treatment facility. Patients have been treated at the Center since 1990. Radiation treatment has been expanded and refined since the Center's opening, and these changes have been based primarily on outcomes seen and evaluated in long-term follow-up. The Radiation Medicine Patient Registry (a multi-year database), which began as an IRB-approved study in 2003, including detailed follow-up of study data collected from 1990 and onward, is designed to track all medical information from patients treated with proton therapy and/or conventional X-ray therapy at Loma Linda University Medical Center. Information gathered from patients treated years or even decades ago helps to determine the most effective use of proton and conventional radiation in caring for patients with cancers and other diseases.

Detailed description

The patient registry will be posted to accomplish three objectives: 1. Perform retrospective research studies on diseases treated with proton therapy and conventional photon radiation. 2. Maintain regular and life-long contact with patients in order to obtain current identification, contact information, and self/parent-reported health status. This information is used to generate better understanding of treatment strategies and, in turn, increase benefits to patients. 3. Enable physicians to review of medical record information and so to identify subjects who may be eligible to participate in future research studies. This requires obtaining permission from registered participants that they may be contacted and asked if they are interested in participating in studies for which they may be eligible, as determined by their medical information contained in the registry.

Interventions

RADIATIONProton or Photon

Sponsors

Loma Linda University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 99 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of benign or malignant tumors or other conditions deemed treatable by proton or conventional photon radiotherapy * Willingness to sign an Informed Consent Document

Exclusion criteria

* There are no specific

Design outcomes

Primary

MeasureTime frameDescription
Disease-free survivalOne yearParticipants will be followed per protocol pre- during- and following treatment per protocol schedule

Secondary

MeasureTime frameDescription
Local recurrenceOne yearParticipants will be followed per protocol pre- during- and following treatment per protocol schedule

Contacts

PRINCIPAL_INVESTIGATORJerry D Slater, MD

Loma Linda University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 9, 2026